His primary scientific interests are in Internal medicine, Procalcitonin, Intensive care medicine, Randomized controlled trial and Respiratory tract infections. Philipp Schuetz has included themes like Gastroenterology, Surgery and Immunology in his Internal medicine study. His Procalcitonin research is multidisciplinary, incorporating perspectives in Bronchitis, Community-acquired pneumonia, Intensive care unit and Antibiotics.
He studied Community-acquired pneumonia and Adverse effect that intersect with Blood pressure. His research integrates issues of Observational study, Predictive value of tests, Prospective cohort study and Pneumonia in his study of Intensive care medicine. He interconnects Emergency department, Discontinuation, Pediatrics and Emergency medicine in the investigation of issues within Randomized controlled trial.
Philipp Schuetz spends much of his time researching Internal medicine, Intensive care medicine, Procalcitonin, Prospective cohort study and Pneumonia. His Internal medicine study incorporates themes from Gastroenterology and Endocrinology. His Gastroenterology research includes themes of Surgery and Immunology.
His studies deal with areas such as Biomarker, Observational study, Sepsis and Malnutrition as well as Intensive care medicine. His study in Procalcitonin is interdisciplinary in nature, drawing from both Antibiotics, Respiratory tract infections, Emergency department, Randomized controlled trial and Intensive care unit. His studies in Prospective cohort study integrate themes in fields like Cohort study, Cohort and Emergency medicine.
Philipp Schuetz focuses on Internal medicine, Odds ratio, Intensive care medicine, Malnutrition and Procalcitonin. His work on Endocrinology expands to the thematically related Internal medicine. His work carried out in the field of Odds ratio brings together such families of science as Interquartile range, Lower risk, Confidence interval, Prospective cohort study and Intensive care unit.
The concepts of his Intensive care unit study are interwoven with issues in Observational study and Emergency medicine. The Critically ill research he does as part of his general Intensive care medicine study is frequently linked to other disciplines of science, such as Context, therefore creating a link between diverse domains of science. His Procalcitonin research focuses on subjects like Antibiotics, which are linked to Respiratory infection.
Internal medicine, Intensive care medicine, Malnutrition, Procalcitonin and Odds ratio are his primary areas of study. His work deals with themes such as Review article and Sepsis, which intersect with Intensive care medicine. His Malnutrition study integrates concerns from other disciplines, such as Intervention, Hazard ratio, Clinical trial and Quality of life.
His Procalcitonin study combines topics from a wide range of disciplines, such as Respiratory tract infections, Antibiotics, Antibiotic Stewardship, Respiratory infection and Intensive care unit. The study incorporates disciplines such as Head and neck cancer and Prospective cohort study, Randomized controlled trial, Surgery, Clinical endpoint in addition to Odds ratio. His Randomized controlled trial research incorporates elements of Survival rate and Mortality rate.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections: The ProHOSP Randomized Controlled Trial
Philipp Schuetz;Mirjam Christ-Crain;Robert Thomann;Claudine Falconnier.
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Philipp Schuetz;Yannick Wirz;Ramon Sager;Mirjam Christ-Crain.
Cochrane Database of Systematic Reviews (2017)
Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future
Philipp Schuetz;Werner Albrich;Beat Mueller.
BMC Medicine (2011)
Procalcitonin Algorithms for Antibiotic Therapy Decisions: A Systematic Review of Randomized Controlled Trials and Recommendations for Clinical Algorithms
Philipp Schuetz;Victor Chiappa;Matthias Briel;Jeffrey L. Greenwald.
JAMA Internal Medicine (2011)
Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
Matthias Briel;Philipp Schuetz;Beat Mueller;Jim Young.
JAMA Internal Medicine (2008)
Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: The REDUCE Randomized Clinical Trial
Jörg D. Leuppi;Philipp Schuetz;Roland Bingisser;Michael Bodmer.
Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial.
Fabian Müller;Mirjam Christ-Crain;Thomas Bregenzer;Martin Krause.
Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial
Claudine Angela Blum;Nicole Nigro;Matthias Briel;Matthias Briel;Philipp Schuetz.
The Lancet (2015)
Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-Analysis
Philipp Schuetz;Philipp Schuetz;Matthias Briel;Mirjam Christ-Crain;Daiana Stolz.
Clinical Infectious Diseases (2012)
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis
Philipp Schuetz;Yannick Wirz;Ramon Sager;Mirjam Christ-Crain;Mirjam Christ-Crain.
Lancet Infectious Diseases (2018)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: